Table 1.
Clinical Characteristics of the Patients with COVID-19 Related Psychotic Symptoms
| Medication (mg/day) | Previous History of Mental Illness (Yes/No) | Time to Full Remission in Days (Reference) |
|---|---|---|
| Quetiapine 500 mg/day Clonazepam 1 mg/day |
No | 1412 |
| N/A | No | N/A13 |
| Olanzapine 10 mg/day | No | 214 |
| Aripiprazole 30 mg/day Clonazepam 4 mg/day | Yes | 1714 |
| Aripiprazole 20 mg/day Lorazepam 3 mg/day |
Yes | 1314 |
| Risperidone 1.5 mg/day Lorazepam 2 mg/day |
No | 314 |
| Olanzapine 25 mg/day Paliperidone depot 350 mg Lorazepam 2 mg/day |
Yes | N/A15 |
| Quetiapine 25 mg/day | No | 416 |
| Lorazepam 1 mg/day Aripiprazole 2 mg/day |
Yes | N/A16 |
| Quetiapine 50 mg twice per day | No | N/A16 |
Abbreviation: N/A, not reported.